床旁超声对内科心肺诊断入院患者住院时长影响:IMFCU-1随机对照试验研究方案
本研究为前瞻性随机对照试验方案,在内科病房纳入250例以心肺诊断入院的患者,随机接受或不接受由内科医生在入院24小时内完成的心脏、肺及股腘静脉床旁超声检查。主要结局为住院时长,次要结局包括诊断与治疗变化、30天再入院及医疗费用,旨在评估多器官床旁超声对临床结局的影响。
要点
- 内科医生于入院24小时内完成心、肺、静脉多器官床旁超声。
- 主要结局为住院时长,次要结局含诊断治疗变化、再入院与费用。
- 患者管理不受方案强制,由治疗团队自行决定。
核心结论
- 该研究方案旨在评估内科心肺诊断入院患者接受多器官床旁超声对住院时长等临床变量的影响。
研究设计与样本
- 前瞻性随机对照试验,在一家三级医院招募250例以心肺诊断收入内科病房的患者,随机分入床旁超声组或无床旁超声组。
- 床旁超声由内科医生在入院24小时内完成,遵循墨尔本大学iHeartScan、iLungScan及两点静脉压缩方案。
关键数值与推荐
- 主要结局为住院时长;次要结局包括诊断和治疗的变化、30天再入院及医疗费用。
- 床旁超声评估内容包括左右心室功能、显著瓣膜病、心包与胸腔积液、实变、肺水肿、气胸及近端深静脉血栓。
- 患者管理不按方案强制,由治疗团队自行决定。
临床怎么用
- 该方案将提供多器官床旁超声在内科住院患者中影响住院时长与临床决策的高级别证据。
局限性
- 研究方案阶段,尚未报告实际结果数据。
- 患者管理不受方案强制,可能影响干预效应的一致性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Point-of-care ultrasound (POCUS) is emerging as a reliable and valid clinical tool that impacts diagnosis and clinical decision-making as well as timely intervention for optimal patient management. This makes its utility in patients admitted to internal medicine wards attractive. However, there is still an evidence gap in all the medical setting of how its use affects clinical variables such as length of stay, morbidity, and mortality. METHODS/DESIGN: A prospective randomized controlled trial assessing the effect of a surface POCUS of the heart, lungs, and femoral and popliteal veins performed by an internal medicine physician during the first 24 h of patient admission to the unit with a presumptive cardiopulmonary diagnosis. The University of Melbourne iHeartScan, iLungScan, and two-point venous compression protocols are followed to identify left and right ventricular function, significant valvular heart disease, pericardial and pleural effusion, consolidation, pulmonary edema, pneumothorax, and proximal deep venous thrombosis. Patient management is not commanded by the protocol and is at the discretion of the treating team. A total of 250 patients will be recruited at one tertiary hospital. Participants are randomized to receive POCUS or no POCUS. The primary outcome measured will be hospital length of stay. Secondary outcomes include the change in diagnosis and management, 30-day hospital readmission, and healthcare costs. DISCUSSION: This study will evaluate the clinical impact of multi-organ POCUS in internal medicine patients admitted with cardiopulmonary diagnosis on the hospital length of stay. Recruitment of participants commenced in September 2018 and is estimated to be completed by March 2020. TRIAL REGISTRATION: Australian and New Zealand Clinical Trial Registry, ACTRN12618001442291. Registered on 28 August 2018.
引用
- Cid X, Canty D, Royse A, et al. Impact of point-of-care ultrasound on the hospital length of stay for internal medicine inpatients with cardiopulmonary diagnosis at admission: study protocol of a randomized controlled trial-the IMFCU-1 (Internal Medicine Focused Clinical Ultrasound) study. Trials. 2020. PMID: 31915052. doi:10.1186/s13063-019-4003-2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。